naproxen has been researched along with jasmonic acid in 1 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (jasmonic acid) | Trials (jasmonic acid) | Recent Studies (post-2010) (jasmonic acid) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 3,814 | 2 | 2,598 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, GJ; Brooke, DG; Denny, WA; Flanagan, JU; Hamilton, EJ; Heinrich, D; Jamieson, SM; Owen, PJ; Raynham, T; Rigoreau, LJ; Samlal, SS; Schroeder, E; Silva, S; Soudy, C; Trivier, E; Turnbull, AP | 1 |
1 other study(ies) available for naproxen and jasmonic acid
| Article | Year |
|---|---|
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Benzoates; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Structure-Activity Relationship | 2012 |